GVHD,Acute Clinical Trial
Official title:
Effects of a Physical Therapy and Therapeutic Exercise Program in Graft-versus-host Disease (GVHD)
Range of motion, antropometric measurements, quality of life questionnaire and 2 minutes walk test will be implemented as an initial assessment. Physical exercise program will take 2 sessions a week for six months, and several follow-ups: before, during and after treatment.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05855707 -
Wharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis
|
Phase 1 | |
| Active, not recruiting |
NCT04522843 -
Analysis of Intestinal Defensin Expression in Acute GVHD
|
||
| Recruiting |
NCT05718791 -
CXCL9 and EASIX for Prediction of Acute Graft Versus Host Disease
|
||
| Recruiting |
NCT05368181 -
MAP-guided Preemptive Therapy of aGvHD
|
Phase 2 | |
| Withdrawn |
NCT05443464 -
Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)
|
Phase 1 | |
| Not yet recruiting |
NCT06315309 -
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
|
Phase 2 | |
| Terminated |
NCT04220632 -
A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04284904 -
Role of aGVHD Biomarkers on aGVHD Risks
|
||
| Not yet recruiting |
NCT06164288 -
Safety and Efficacy Study of hAESCs Therapy for aGVHD
|
Phase 1 | |
| Recruiting |
NCT06462365 -
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
|
Phase 1 |